Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2

Maria Alsina

MD, PhD

🏢Vall d'Hebron Institute of Oncology🌐Spain

Attending Physician, GI Cancer Program

35
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Maria Alsina is a rising leader in gastric cancer translational research at Vall d'Hebron. She has contributed to pivotal clinical trials of HER2 and Claudin 18.2-directed therapies and has advanced biomarker strategies for patient selection. Her work bridges preclinical molecular insights with clinical trial design in gastroesophageal cancers.

Share:

🧪Research Fields 研究领域

Gastric cancer
HER2-targeted therapy
Claudin 18.2
Translational research
Biomarker development

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Maria Alsina 的研究动态

Follow Maria Alsina's research updates

留下邮箱,当我们发布与 Maria Alsina(Vall d'Hebron Institute of Oncology)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment